# Leading Pharma, LLC – FDA Inspection, Apr 14, 2017

Source: https://www.keypedia.com/records/fda_inspections/leading-pharma-llc/efbfdb8f-5704-4965-b98b-7af22956981e
Source feed: FDA_Inspections

> FDA inspection 1010916 of Leading Pharma, LLC, April 14, 2017. Classification: Voluntary Action Indicated (VAI). 2 citations under 21 CFR part 314. Form 483 issued. 10 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1010916
- Company Name: Leading Pharma, LLC
- Inspection Date: 2017-04-14
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Postmarket Surv. and Epidemiology
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 2

## Related Documents

- [FDA Inspection 1251315 - 2024-10-21](https://www.keypedia.com/records/fda_inspections/leading-pharma-llc/93fdc81c-a4f9-4b4b-b685-064a805089a3)
- FDA Inspection 1129205 - 2020-08-11
- [FDA Inspection 1079111 - 2019-01-31](https://www.keypedia.com/records/fda_inspections/leading-pharma-llc/43dce4fe-af89-41b7-a83e-fbbc3182626f)
- FDA Inspection 1067964 - 2018-08-31
- FDA Inspection 965261 - 2016-03-10

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/zakaria-i-ganiyu/59c3a596-f3fc-43d9-9fa9-b763aec375d1)

Company: https://www.keypedia.com/companies/leading-pharma-llc/9cbe169a-2e1b-4cdb-848c-209798a79db0

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c